WOLVERINE ASSET MANAGEMENT LLC - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is and the CUSIP is 45773HAB8. A total of 4 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
WOLVERINE ASSET MANAGEMENT LLC ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$5,247,864
-0.1%
5,690,0000.0%0.06%
-4.8%
Q2 2023$5,252,453
+22.3%
5,690,0000.0%0.06%
+21.6%
Q1 2023$4,294,583
-15.6%
5,690,0000.0%0.05%
-3.8%
Q4 2022$5,089,946
+14.4%
5,690,000
+15.8%
0.05%
+10.4%
Q3 2022$4,451,000
-24.0%
4,915,000
-23.4%
0.05%
-18.6%
Q2 2022$5,858,000
-3.7%
6,415,0000.0%0.06%0.0%
Q1 2022$6,081,000
-23.1%
6,415,0000.0%0.06%
-20.3%
Q4 2021$7,907,000
+2.3%
6,415,000
+23.6%
0.07%
+10.4%
Q3 2021$7,733,000
-15.3%
5,190,0000.0%0.07%
-4.3%
Q2 2021$9,130,000
-3.4%
5,190,0000.0%0.07%
-12.5%
Q1 2021$9,456,000
+35.3%
5,190,000
+23.9%
0.08%
+56.9%
Q4 2020$6,989,000
-22.7%
4,190,0000.0%0.05%
-36.2%
Q3 2020$9,043,000
-17.3%
4,190,000
+91.3%
0.08%
-27.3%
Q2 2020$10,938,000
+74.2%
2,190,000
-47.7%
0.11%
+20.9%
Q1 2020$6,279,0004,190,0000.09%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
AQR Arbitrage LLC 4,225,000$3,897,5630.18%
WOLVERINE ASSET MANAGEMENT LLC 5,690,000$5,247,8640.06%
D. E. Shaw & Co., Inc. 6,500,000$6,049,2250.01%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of INOVIO PHARMACEUTICALS INC shareholders